help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersson, A.-M.
Right arrow Articles by Skakkebæk, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, A.-M.
Right arrow Articles by Skakkebæk, N. E.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 12 4451-4458
Copyright © 1998 by The Endocrine Society


Original Studies

Different Roles of Prepubertal and Postpubertal Germ Cells and Sertoli Cells in the Regulation of Serum Inhibin B Levels1

Anna-Maria Andersson, Jørn Müller and Niels E. Skakkebæk

Department of Growth and Reproduction, University of Copenhagen, DK-2100 Copenhagen, Denmark

Address all correspondence and requests for reprints to: Anna-Maria Andersson, M.Sc, Ph.D., Department of Growth and Reproduction, section GR 5064, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark. E-mail: anna{at}rh.dk


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
To elucidate the role of germ cells in the regulation of inhibin B secretion, serum inhibin B levels in prepubertal boys and adult men whom had a concurrent testicular biopsy showing either normal or impaired testicular function were compared. In addition, by immunohistochemistry the cellular localization of the two subunits of inhibin B ({alpha} and ßB) were examined in adult testicular tissue with normal spermatogenesis, spermatogenic arrest, or Sertoli cell only tubules (SCO) as well as in normal testicular tissue from an infant and a prepubertal boy. Adult men with testicular biopsy showing normal spermatogenesis (n = 8) or spermatogenic arrest (n = 5) had median inhibin B levels of 148 pg/mL (range, 37–463 pg/mL) and 68 pg/mL (range, 29–186 pg/mL), respectively, corresponding to normal or near-normal levels of our reference population (165 and 31–443 pg/mL; n = 358). Men with SCO (n = 9) had undetectable or barely detectable (n = 1) serum levels of inhibin B. In contrast to adults, prepubertal boys with SCO (n = 12) all had measurable serum inhibin B levels that corresponded to our previously determined normal range in healthy prepubertal boys (n = 114). However, in postpubertal samples from the same SCO boys, inhibin B levels were undetectable as in the adult SCO men. Intense inhibin {alpha}-subunit immunostaining was evident in Sertoli cells in both prepubertal and adult testes. In the prepubertal testis, positive immunostaining for the ßB-subunit was observed in Sertoli cells. In the adult testis, intense immunostaining for the ßB-subunit was evident in germ cells from the pachytene spermatocyte to early spermatid stages and to a lesser degree in Leydig cells, but not in Sertoli cells or other stages of germ cells. Thus, surprisingly, in adult men the two subunits constituting inhibin B were expressed by different cell types. We speculate that during puberty Sertoli cell maturation induces a change in inhibin subunit expression. Thus, immature Sertoli cells express both {alpha} and ßB inhibin subunits, whereas fully differentiated Sertoli cells only express the {alpha}-subunit. The correlation in adult men between serum inhibin B levels and spermatogenesis may be due to the fact that inhibin B in adult men is possibly a joint product of Sertoli cells and germ cells, including the stages from pachytene spermatocytes to early spermatids.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
THE GONADAL peptide hormone inhibin, which exerts negative feedback regulation of pituitary production and secretion of FSH, exists in two principal bioactive forms: the inhibin A dimer, consisting of an {alpha}-subunit and a ßA-subunit, and the inhibin B dimer, consisting of an {alpha}-subunit and a ßB-subunit (1). The subunits are covalently linked by a disulfide bond. By the implementation of a new immunoassay format that made it possible to measure these two bioactive inhibin forms specifically, it has been shown that inhibin B is the principal circulating bioactive inhibin form in men (2). Activins are structurally related dimers that are composed of two ß-subunits and that can stimulate FSH release. Inhibin B is presumed to be produced primarily by the Sertoli cells of the testis based on in vitro studies (3, 4, 5, 6) and the localization of inhibin subunit peptide and messenger ribonucleic acid in testicular tissue from rats (7, 8, 9), primates (10), and humans (9) by immunohistochemistry and in situ hybridization. However, the regulation of inhibin B secretion is still largely unknown. Studies of the role of gonadotropins or androgens in inhibin regulation are equivocal. Several studies indicate that the presence of specific germ cell types may stimulate the production and secretion of inhibin as shown in the rat (11, 12, 13, 14) and indicated in men with impaired spermatogenesis, who generally have very low or undetectable serum inhibin B levels (15). On the other hand, we have recently shown that prepubertal boys, who do not have spermatogenesis and therefore lack the relevant germ cell types, secrete inhibin B in readily measurable levels (16, 17). To further elucidate the role of germinal cells in the regulation of inhibin B secretion we measured serum inhibin B levels in men with either normal ongoing spermatogenesis, spermatogenic arrest, or Sertoli cell only syndrome (SCO) based on a testicular biopsy. In addition, we measured serum inhibin B levels in boys and adolescents previously treated for acute lymphoblastic leukemia (ALL), some of whom became SCO as a result of the treatment. The expression and cellular localization of inhibin {alpha}- and ßB-subunits were investigated using immunohistochemistry in testicular biopsies from adult men with normal or abnormal spermatogenesis and from prepubertal boys.

Based on our observations, we hypothesize that inhibin B in adult men may be produced by Sertoli cells and spermatocytes in collaboration.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

Prepubertal boys. Simultaneous testicular biopsies and blood samples were available from 34 boys previously treated for ALL, who had testicular biopsy performed for screening for lymphoblastic infiltration. Of these boys, 12 acquired a SCO pattern as a consequence of their treatment, 13 boys had testes with normal numbers of germinal cells, and 9 boys had testes with reduced numbers of germinal cells after termination of treatment for ALL. From 17 boys, longitudinal blood samples and testicular biopsies were available, and from 6 of these boys postpubertal blood samples were also available. For immunocytochemistry, testicular tissue was obtained at autopsy from 2 boys, aged 4.5 months and 7 yr, who had died in sudden accidents.

Adult men. Concurrent testicular biopsies and blood samples were obtained from men referred to our clinic for infertility and from testicular cancer patients who had biopsy performed as screening for carcinoma in situ in the contralateral testis. Based on the testicular biopsy and semen parameters, men were grouped according to the presence of normal spermatogenesis (n = 8), spermatogenic arrest (n = 5), or SCO syndrome (n = 9). The men with normal spermatogenesis included five men with obstruction of the efferent ducts, two testicular cancer patients with one remaining normal testis after unilateral orchidectomy, and one patient with normal spermatogenesis in one testis and spermatogenic arrest of the other. Men with spermatogenic arrest were defined as having bilateral spermatogenic arrest and azoospermia. The SCO men were defined as having SCO and azoospermia and included four men with idiopathic bilateral SCO and five unilaterally orchidectomized men with SCO in the remaining testis due to irradiation for carcinoma in situ.

Serum samples and testicular biopsies

Serum was separated after clotting and was stored at -20 C until hormone measurements. Adult serum samples were measured within a few weeks from the time of sampling, whereas the time of storage of serum samples from ALL treated boys varied from 15 yr to a few months. Serum inhibin B was measured in an enzyme immunometric assay, previously described (18). This assay is specific for the bioactive inhibin B dimer ({alpha}-ßB). The sensitivity of the inhibin B assay was 18 pg/mL, and the intra- and interassay coefficients of variation were less than 12% and less than 17%, respectively.

Testicular biopsies of approximately 2 x 2 mm (boys) or 3 x 3 mm (adult men) were obtained by open surgery and fixed in Stieve’s fixative. For evaluation of spermatogenic status, slides were stained with hematoxylin-eosin before evaluation by light microscopy.

Testicular biopsy and blood sampling in boys treated for ALL as screening for testicular relapse was approved by the local ethical board. In the adult subjects, testicular biopsies and blood samples were performed as part of a clinical routine evaluation. The patients had given informed consent to the procedures.

Immunohistochemistry

Sections (4 µm) were mounted on SuperFrost Plus slides (Menzel, Braunschweig, Germany) and dried overnight at 50 C. Before incubation with primary antibody, sections were dewaxed, rehydrated in graded ethanol, and washed in water and 0.05 mol/L Tris-HCl (pH 7.4) and 0.15 mol/L NaCl (TBS). Sections were subjected to antigen retrieval by microwaving in 0.01 mol/L citrate buffer (pH 5.5) on full power (750 watts) for 2 min and on 40% power for an additional 18 min. Sections were allowed to cool at room temperature for 20 min before being washed for 5 min in TBS and subsequently incubated in 1% H2O2 in TBS for 30 min to block endogenous peroxidase. Purified monoclonal antibodies directed against {alpha}-subunit (19) (code R1) were used at a concentration of 2 µg/mL, and two different antibodies against the ßB-subunit (18) (code C5 and 12/13) were used at concentrations of 25 and 5 µg/mL, respectively. The C5 and 12/13 antibodies directed against the ßB-subunit had 0.5–1% cross-reactivity with the ßA-subunit (18). Primary antibodies were diluted in TBS and incubated on sections in a humid chamber overnight at 4 C. The following day sections were washed three times in TBS (3 min/wash), incubated with biotinylated goat antimouse Igs (Zymed histostain kit, Zymed Laboratories, Inc., San Francisco, CA) for 30 min, and then washed again three times in TBS. For detection of bound antibodies, sections were subsequently incubated with peroxidase-conjugated streptavidin-biotin complex (Zymed Histostain) for 30 min, followed by washing three times in TBS. Color was developed in an aminoethyl carbazole substrate solution (Zymed Histostain kit). After 6–10 min of color development, sections were washed in tap water, counterstained with hematoxylin, and mounted in glycerol vinyl alcohol (Zymed Laboratories, Inc.). On sections from prepubertal testes an alternative immunostaining procedure was also used. In the alternative procedure the second layer of antibody was exchanged with unlabeled rabbit antimouse antibody (Dako Corp., Glostrup, Denmark) diluted 1:50 in TBS, and the third layer was exchanged with alkaline phosphatase-antialkaline phosphatase complex (Dako Corp.) diluted 1:25 in TBS. After a final wash in 0.05 mol/L Tris-HCl (pH 8.7), color was developed in a new fuchsin substrate solution (Sigma, St. Louis, MO). The specificity of the antibodies was controlled by using normal mouse serum instead of primary antibodies and by preabsorbing the antibodies with the corresponding peptide.

Statistics

Differences in inhibin B levels among men with normal spermatogenesis, spermatogenic arrest, and SCO were tested by the Mann-Whitney U test. The influence of storage on serum inhibin B levels was tested by linear regression on data that were square root transformed to obtain a good approximation to the normal distribution.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Serum inhibin B levels in boys and adult men

The median and range of serum inhibin B levels within the different groups are summarized in Table 1Go. For comparison, serum inhibin B levels in a normal population of 114 prepubertal boys and 358 adult men, which have been described previously (17), are also included in the table.


View this table:
[in this window]
[in a new window]
 
Table 1. Serum inhibin B levels (median and range) in prepubertal boys and adult men with normal or impaired testicular function

 
Serum inhibin B levels in samples from boys treated for ALL with either normal testicular pattern or SCO are plotted according to age in relation to normal ranges in Fig. 1Go. Sera from boys treated for ALL had been stored at -20 C from a few weeks up to 15.3 yr (median, 4.8 yr) before being analyzed for inhibin B. Because of the large variation in length of storage, the long term storage stability of inhibin B had to be considered. There was no time trend in prepubertal inhibin B levels when plotted according to storage time (r2 = 0.005; P = 0.638), indicating that inhibin B was relatively stable during long term storage. Furthermore, serum inhibin B levels in prepubertal boys treated for ALL with normal testis pattern were all within the normal range for prepubertal boys, as were the levels in prepubertal boys with SCO. In all postpubertal samples from boys who acquired a SCO pattern, serum inhibin B levels were undetectable (Fig. 1Go).



View larger version (42K):
[in this window]
[in a new window]
 
Figure 1. Serum inhibin B levels in prepubertal boys treated for ALL plotted against age. Actual testicular status at time of sampling is indicated by the marks as defined in the legend. The gray area (5th and 95th percentiles) indicates reference levels in normal healthy boys (16 ). The lines connect longitudinal samples in the same individual.

 
Serum inhibin B levels in the group of men with testicular biopsies showing normal spermatogenesis, including the three men who only had one testis with normal spermatogenesis, were all within the normal range for adult men. Serum inhibin B levels in the group of men with spermatogenic arrest were in the low normal range. However, there was no statistically significant difference between the levels in men with normal spermatogenesis and those in men with spermatogenic arrest (by Mann-Whitney U test). In contrast, all men with SCO, except one, had unmeasurable serum levels of inhibin B.

Expression of inhibin B subunits in human prepubertal and adult testes

In prepubertal testes, intense positive immunostaining for inhibin {alpha}-subunit was observed that was localized to Sertoli and interstitial cells (Fig. 2AGo). Positive immunostaining for inhibin ßB-subunit was also observed in Sertoli cells of prepubertal testes (Fig. 2BGo). In adult testes with ongoing spermatogenesis, positive immunostaining for inhibin {alpha}-subunit was observed in both Sertoli cells and Leydig cells (Fig. 3Go, A and B). A similar {alpha}-subunit immunostaining pattern was observed in testes with spermatogenic arrest (Fig. 4AGo) and in testes with SCO (Fig. 4BGo). In adult testes with normal spermatogenesis and with spermatogenic arrest, intense immunostaining for the inhibin ßB-subunit was located in germ cells from pachytene spermatocytes to round spermatids (Figs. 3Go, C and D, and 4C). An identical staining pattern was observed using two different monoclonal anti-ßB antibodies. In contrast, no staining for the inhibin ßB-subunit was observed in Sertoli cells; spermatogonia; preleptotene, leptotene, or zygotene spermatocytes; or late spermatids (from types Sb–Sd). However, Leydig cells were also positive for ßB-subunit immunostaining. In adult testes with SCO, no intratubular immunostaining for the ßB-subunit was observed (Fig. 4DGo). Occasionally, faint ßB-subunit immunostaining was observed in a few Leydig cells, but, in general, Leydig cells were also negative for ßB-subunit staining in SCO testes.



View larger version (83K):
[in this window]
[in a new window]
 
Figure 2. Cellular localization of inhibin {alpha}- and inhibin/activin ßB-subunits in 4.5-month-old postnatal human testis. Strong immunostaining for inhibin {alpha}-subunit was observed in both interstitial and Sertoli cells (A). A weak, but positive, immunostaining for the inhibin/activin ßB-subunit could be observed in Sertoli cells (B) when the monoclonal anti-ßB antibody code C5 was used. Immunostaining with the monoclonal anti-ßB antibody code 12/13 resulted in an identical staining pattern (not shown). Immunostaining with preimmune mouse serum (C) or preabsorbed antibodies (not shown) did not result in any positive staining. Magnification, x250. The staining pattern for the {alpha}- and ßB-subunits in the 4.5-month-old testis was similar to the pattern observed in the 7-yr-old testis (not shown).

 


View larger version (121K):
[in this window]
[in a new window]
 
Figure 3. Cellular localization of inhibin {alpha}- and inhibin/activin ßB-subunits in adult human testis with normal spermatogenesis. Strong immunostaining for inhibin {alpha}-subunit was observed in both Leydig and Sertoli cells (A, x250; B, x630). Immunostaining for inhibin/activin ßB-subunit with the anti-ßB antibody code C5 was localized to pachytene spermatocytes, round spermatides, and Leydig cells (C, x250; D, x630). Immunostaining with the monoclonal anti-ßB antibody code 12/13 resulted in an identical staining pattern (not shown). Immunostaining with preimmune mouse serum (E, x250) or with preabsorbed antibodies (not shown) did not result in any positive staining.

 


View larger version (164K):
[in this window]
[in a new window]
 
Figure 4. Cellular localization of inhibin {alpha}- and inhibin/activin ßB-subunits in adult human testis with spermatogenic arrest and SCO. Strong immunostaining for inhibin {alpha}-subunit was observed in Leydig and Sertoli cells in both testes with spermatogenic arrest (A) and those with SCO (B). Immunostaining for inhibin/activin ßB-subunit in testes with spermatogenic arrest (C) was similar to the staining observed in testis with complete spermatogenesis, with localization of the staining to pachytene spermatocytes, round spermatides, and Leydig cells. SCO testes were generally negative for staining for the ßB-subunit (D), although occasionally faint ßB-subunit staining could be observed in a few Leydig cells. Immunostaining with preimmune mouse serum [spermatogenic arrest (E) and SCO (F)] or with preabsorbed antibodies (not shown) did not result in any positive staining. Magnification, x250.

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
In our study in which serum inhibin B levels could be directly correlated to the testicular status based on a concurrent testicular biopsy, we have demonstrated that the regulation of inhibin B secretion changes during puberty. Whereas serum inhibin B levels in prepubertal boys were independent of the presence of germinal cells, serum inhibin B levels in postpubertal men were closely related to the presence of germinal cells from pachytene spermatocytes to early spermatids. In the rat, inhibin production has also been correlated to the presence of certain germ cell types (11, 12, 13, 14), although in this species inhibin production, as measured in an {alpha}-subunit assay, was highest in the presence of late spermatids.

Human adult serum inhibin B levels, however, were not dependent on complete spermatogenesis, as serum inhibin B levels were measurable in all five men with bilateral spermatogenic arrest at the spermatocyte level, although the inhibin B levels tended to be lower than those observed in a normal male population, including men with documented complete spermatogenesis. Furthermore, levels of serum inhibin B in men with only one normal functioning testis were well within the normal range, indicating that the remaining testis after unilateral orchidectomy may be able to compensate for the missing testis with respect to inhibin B secretion.

The regulation of inhibin B secretion in prepubertal boys is not clear. The localization of both {alpha}- and ßB-subunits to interstitial and Sertoli cells in the prepubertal human testis observed in this study is in agreement with previous findings in the rat (8, 9) and human (9). We recently showed that serum inhibin B levels are temporarily highly elevated postnatally, presumably as a consequence of the temporary activation of the pituitary shortly after birth (17), as also shown previously (20), indicating that inhibin B secretion in the newborn is under the influence of gonadotropins. Later in childhood, gonadotropin levels are low, but perhaps sufficient to sustain the readily measurable serum levels of inhibin B observed throughout childhood (16). Thus, serum inhibin B levels in hypogonadotropic boys are in the low range of healthy boys (21), although this may be due to a reduced number of Sertoli cells rather than to decreased inhibin B production caused by low FSH levels. Compared to the staining intensity observed for the ßB-subunit in the adult testis, the staining in prepubertal testes was relatively weak. This was also true in the testis from a boy aged 4.5 months, although this is an age when serum inhibin B levels is known to be increased above adult levels (17).

Several studies showing localization of the inhibin {alpha}-subunit in human testis exist that, in general, agree on the localization of this subunit to the Sertoli cells and interstitial/Leydig cells in adult testes (22, 23, 24, 25). Inhibin ßB-subunit expression has previously been localized to Sertoli cells in the adult rat (8, 9) and monkey (10). Recently, a study on the immunolocalization of the inhibin/activin ßB-subunit in the adult human testis using the same antibodies as in our present study was published that showed colocalization of the {alpha}- and ßB-subunits in the Sertoli cells (26). In contrast to these findings, we found that the ßB-subunit was localized to pachytene spermatocytes and round spermatids as well as to Leydig cells, whereas the {alpha}-subunit was localized to Sertoli cells and Leydig cells in the adult human testis. We do not know the reason for this discrepancy, but it may be due to differences in the fixation and processing of the tissue. The facts that we were able to eliminate our ßB-subunit staining pattern by preabsorbing the antibody with a ßB peptide, that the staining pattern was highly reproducible in several different tissue section from different men, and that our ßB-subunit staining was restricted to selected germ cell types with no or negligible background staining of other cell types strongly indicate that our ßB-subunit staining was specific. However, as both subunits are needed to produce inhibin B, our findings raises the question of where circulating inhibin B is produced in the adult human testis. As both subunits are present in Leydig cells, it cannot be excluded that these cells contribute to the circulating levels of inhibin B. However, studies in rats have shown that the major route via which inhibin reaches the bloodstream is through secretion into the seminiferous tubular fluid, thus supporting the idea of an intratubular production of inhibin (27). Alternatively, it may be speculated that the Sertoli cells express the inhibin ßB-subunit at levels below the sensitivity of our immunohisto-chemistry.

The site of dimerization of inhibin subunits is not known. By electron microscopy, evidence of transfer of inhibin {alpha}-subunit from Sertoli cells to spermatocytes has been reported in the human testis (24). However, although inhibin subunit dimerization may take place intracellularly in the spermatocytes, it could also theoretically take place extracellularly. Creation of a disulfide bond from the sulfhydryl groups of two cystein residues is a passive reaction that does not require energy and that takes place in a nonreducing environment, such as in the endoplasmic reticulum, Golgi, coated vesicles, or even extracellular fluid. Manson et al. have shown that the propeptide sequences present in the ß-subunit precursors are necessary for dimerization, presumably by providing the proper configuration for the involved cystein residues to be exposed (28, 29). However, several studies have shown that a high proportion of the inhibin forms in plasma consist of unprocessed or partly processed precursor dimers (30, 31), indicating that the structural elements necessary for dimerization of subunits are still present after secretion. Further processing of inhibin/activin precursors into the bioactive hormone by cleavage of the proprotein region can also take place extracellularly (32).

We speculate that in the adult human testis, inhibin B may be a joint product of Sertoli cells and spermatocytes, and hence the change in localization of the ßB subunit during maturation may explain why serum inhibin B levels are germ cell dependent in the mature testis and not in the immature testis in man. Furthermore, our hypothesis that inhibin subunit dimerization and processing may take place postsecretionally may explain the abundance of non- or partly processed as well as monomeric forms of inhibin in serum. The five men with spermatogenic arrest who were included in this study all had spermatogenic progress that included the level of pachytene spermatocytes and all had measurable serum inhibin B levels. The somewhat lower serum inhibin B levels in these men could be explained by the fact that, in general, they have fewer spermatocytes beyond the pachy-tene stage and no spermatids. If, as we believe, ßB-subunit expression by pachytene spermatocytes and round spermatids correlates with serum inhibin B levels, we would expect men with spermatogenic arrest at a level before the pachytene stage to have very low or unmeasurable serum inhibin B levels.

ßB-subunits may also bind together as homodimers to make activin B. Thus, the expression of the ßB-subunit by certain stages of spermatocytes may not have anything to do with inhibin B, but, rather, may imply expression of activin B by these types of spermatocytes. As no activin B dimer-specific antibody is available to our knowledge, it is not possible by immunohistochemistry or in situ hybridization to distinguish whether the observed ßB peptide expression in spermatocytes is present as free ßB-subunits or activin B dimers. To our knowledge no specific activin B immunoassays are presently available, but development of such an assay would facilitate the specific quantitative measurement of activin B in enriched spermatocyte preparations and thus aid in solving this question.

In conclusion, during pubertal maturation of the human male, testicular inhibin B production becomes germ cell dependent. This change in inhibin B regulation may be explained by a maturational change in the localization of expression of the inhibin ßB-subunit from the Sertoli cells to specific germ cell stages in the spermatogenic process, namely to cells from the pachytene spermatocyte to round spermatid stages. Our suggestions that inhibin B is a joint product, and that the subunits of which may originate from different cell types propose to our knowledge a new concept in the regulation of peptide hormone and growth factor expression. This maturational change in the production and regulation of inhibin B levels thus provides a close link between serum inhibin B levels (and thus FSH feedback regulation) and spermatogenesis.


    Acknowledgments
 
We thank Stine Ehlern Jessen and Majbrit Kvist for skilled technical assistance, and we are grateful to Dr. Richard Sharpe for his constructive comments during the preparation of this manuscript.


    Footnotes
 
1 This work was supported by the Danish Research Councils (Grant 9700833). Back

Received June 23, 1998.

Revised August 27, 1998.

Accepted September 17, 1998.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. De Kretser DM, McFarlane JR. 1996 Inhibin in the male. J Androl. 17:179–82.[Free Full Text]
  2. Illingworth PJ, Groome NP, Bryd W, et al. 1996 Inhibin-B: a likely candidate for the physiologically important form of inhibin in man. J Clin Endocrinol Metab. 81:1321–1325.[Abstract]
  3. Steinberger A, Steinberger E. 1976 Secretion of an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology. 99:918–921.[Abstract]
  4. Verhoeven G, Franchimont P. 1983 Regulation of inhibin secretion by Sertoli cell-enriched cultures. Acta Endocrinol (Copenh). 102:136–143.[Medline]
  5. Skinner MK, McLachlan RI, Bremner WJ. 1989 Stimulation of sertoli cell inhibin secretion by the testicular paracrine factor PModS. Mol Cell Endocrinol. 66:239–249.[CrossRef][Medline]
  6. Grootenhuis AJ, Timmerman MA, Hordijk PL, de Jong FH. 1990 Inhibin in immature rat Sertoli cell conditioned medium: a 32 kDa alfabeta-B dimer. Mol Cell Endocrinol. 70:109–116.[CrossRef][Medline]
  7. Merchenthaler I, Culler MD, Petrusz P, Negro-Vilar A. 1987 Immunocytochemical localization of inhibin in rat and human reproductive tissues. Mol Cell Endocrinol. 54:239–243.[CrossRef][Medline]
  8. Roberts V, Meunier H, Sawchenko PE, Vale W. 1989 Differential production and regulation of inhibin subunits in rat testicular cell types. Endocrinology. 125:2350–2359.[Abstract]
  9. Majdic G, McNeilly AS, Sharpe RM, Evans LR, Groome NP, Saunders PTK. 1997 Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. Endocrinology. 138:2136–2147.[Abstract/Free Full Text]
  10. Zhang T, Zhou H-M, Liu Y-X. 1997 Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes. Mol Hum Reprod. 3:223–231.[Abstract/Free Full Text]
  11. Bhasin S, Krummen L, Morelos BS, et al. 1989 Stage-dependent expression of inhibin {alpha} and ßB subunits during the cycle of the rat seminiferous epithelium. Endocrinology. 124:987–991.[Abstract]
  12. Pineau C, Sharpe RM, Saunders PT, Gerard N, Jegou B. 1990 Regulation of Sertoli cell inhibin production and of inhibin {alpha}-subunit mRNA levels by specific germ cell types. Mol Cell Endocrinol. 72:13–22.[CrossRef][Medline]
  13. Allenby G, Foster PMD, Sharpe RM. 1991 Evidence that secretion of immunoactive inhibin by seminiferous tubules from the adult rat testis is regulated by specific germ cell types: correlation between in vivo and in vitro studies. Endocrinology. 128:467–476.[Abstract]
  14. Klaij IA, van Pelt AMM, Timmerman MA, Blok LJ, de Rooij DG, de Jong FH. 1994 Expression of inhibin subunit mRNAs and inhibin levels in the testes of rats with stage-synchronized spermatogenesis. J Endocrinol. 141:131–141.[Abstract]
  15. Anawalt BD, Bebb RA, Matsumoto AM, et al. 1996 Serum inhibin B levels reflect sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab. 81:3341–3345.[Abstract]
  16. Andersson A-M, Juul A, Petersen JH, Müller J, Groome NP, Skakkebæk NE. 1997 Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone testosterone and estradiol levels. J Clin Endocrinol Metab. 82:3976–3982.[Abstract/Free Full Text]
  17. Andersson A-M, Toppari J, Haavisto A-M, et al. 1998 Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab. 83:675–681.[Abstract/Free Full Text]
  18. Groome NP, Illingworth PJ, O’Brien M, et al. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 81:1401–1405.[Abstract]
  19. Groome NP, Illingworth PJ, O’Brien M, et al. 1994 Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf). 40:717–723.[Medline]
  20. Burger HG, Yamada Y, Bangah ML, McCloud PI, Warne GL. 1991 Serum gonadotropin, sex steroid and immunoreactive inhibin levels in the first two years of life. J Clin Endocrinol Metab. 72:682–686.[Abstract]
  21. Raivio T, Toppari J, Perheentupa A, McNeilly AS, Dunkel L. 1997 Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone. Lancet. 350:263–264.[CrossRef][Medline]
  22. Bergh A, Cajander S. 1990 Immunohistochemical localization of inhibin-alpha in the testes of normal men and in men with testicular disorders. Int J Androl. 13:463–469.[Medline]
  23. Vliegen MK, Schlatt S, Weinbauer GF, Bergmann M, Groome NP, Nieschlag E. 1993 Localization of inhibin/activin subunits in the testis of adult nonhuman primates and men. Cell Tissue Res. 273:261–268.[CrossRef][Medline]
  24. Forti G, Vannelli GB, Barni T, Balboni GC, Orlando C, Serio M. 1992 Sertoli-germ cells interactions in the human testis. J Steroid Biochem Mol Biol. 43:419–422.[CrossRef][Medline]
  25. Vannelli GB, Barni T, Forti G, et al. 1992 Immunolocalization of inhibin {alpha}-subunit in the human testis. A light- and electron-microscopy study. Cell Tissue Res. 269:221–227.[CrossRef][Medline]
  26. Anderson RA, Irvine DS, Balfour C, Groome NP, Riley SC. 1998 Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. Hum Reprod. 13:920–926.[Abstract/Free Full Text]
  27. Maddocks S, Sharpe RM. 1989 The route of secretion of inhibin from the rat testis. J Endocrinol 120:R5–R8.
  28. Gray AM, Mason AJ. 1990 Requirement for activin A and transforming growth factor-ß1 pro-regions in homodimer assembly. Science. 247:1328–1330.[Abstract/Free Full Text]
  29. Mason AJ. 1994 Functional analysis of the cysteine residues of activin A. Mol Endocrinol. 8:325–332.[Abstract]
  30. Robertson DM, Sullivan J, Watson M, Cahir N. 1995 Inhibin forms in human plasma. J Endocrinol. 144:261–269.[Abstract]
  31. Robertson DM, Cahir N, Findlay JK, Burger HG, Groome N. 1997 The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J Clin Endocrinol Metab. 82:889–896.[Abstract/Free Full Text]
  32. Mason AJ, Farnworth PG, Sullivan J. 1996 Characterization and determination of the biological activites of noncleavable high molecular weight forms of inhibin A and activin A. Mol Endocrinol. 10:1055–1065.[Abstract]



This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
F. De Luca, V. Mitchell, M. Wasniewska, T. Arrigo, M. F. Messina, M. Valenzise, L. de Sanctis, and N. Lahlou
Regulation of spermatogenesis in McCune-Albright syndrome: lessons from a 15-year follow-up.
Eur. J. Endocrinol., June 1, 2008; 158(6): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. A. Boepple, F. J. Hayes, A. A. Dwyer, T. Raivio, H. Lee, W. F. Crowley Jr, and N. Pitteloud
Relative Roles of Inhibin B and Sex Steroids in the Negative Feedback Regulation of Follicle-Stimulating Hormone in Men across the Full Spectrum of Seminiferous Epithelium Function
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1809 - 1814.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
E. Gougoudi, E. Pikoulis, I. Karavokyros, K. Gorgas, E. Felekouras, S. Georgopoulos, C. Tsigris, A. Giannopoulos, and Z. Zachariou
Outcome of Fowler-Stephens Operation for Undescended Testes: An Experimental Study
J Androl, November 1, 2007; 28(6): 813 - 820.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
W. Dhooge, N. Van Larebeke, F. Comhaire, and J.-M. Kaufman
Reproductive Parameters of Community-Dwelling Men From 2 Regions in Flanders Are Associated With the Consumption of Self-Grown Vegetables
J Androl, November 1, 2007; 28(6): 836 - 846.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
W. Dhooge, N. Van Larebeke, F. Comhaire, and J.-M. Kaufman
Regional Variations in Semen Quality of Community-Dwelling Young Men From Flanders Are Not Paralleled by Hormonal Indices of Testicular Function
J Androl, May 1, 2007; 28(3): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Wikstrom, C. E. Hoei-Hansen, L. Dunkel, and E. Rajpert-De Meyts
Immunoexpression of Androgen Receptor and Nine Markers of Maturation in the Testes of Adolescent Boys with Klinefelter Syndrome: Evidence for Degeneration of Germ Cells at the Onset of Meiosis
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
T. Raivio, A. M Wikstrom, and L. Dunkel
Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome
Eur. J. Endocrinol., January 1, 2007; 156(1): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K. M Main, J. Toppari, and N. E Skakkebaek
Gonadal development and reproductive hormones in infant boys
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S51 - S57.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Bergada, C. Milani, P. Bedecarras, L. Andreone, M. G. Ropelato, S. Gottlieb, C. Bergada, S. Campo, and R. A. Rey
Time Course of the Serum Gonadotropin Surge, Inhibins, and Anti-Mullerian Hormone in Normal Newborn Males during the First Month of Life
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4092 - 4098.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
Y Okuma, A E O'Connor, T Hayashi, K L Loveland, D M de Kretser, and M P Hedger
Regulated production of activin A and inhibin B throughout the cycle of the seminiferous epithelium in the rat.
J. Endocrinol., August 1, 2006; 190(2): 331 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Soriano-Guillen, V. Mitchell, J.-C. Carel, P. Barbet, M. Roger, and N. Lahlou
Activating Mutations in the Luteinizing Hormone Receptor Gene: A Human Model of Non-Follicle-Stimulating Hormone-Dependent Inhibin Production and Germ Cell Maturation
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3041 - 3047.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Walton, R. A. L. Bayne, I. Wallace, D. T. Baird, and R. A. Anderson
Direct Effect of Progestogen on Gene Expression in the Testis during Gonadotropin Withdrawal and Early Suppression of Spermatogenesis
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2526 - 2533.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. J. Winters, C. Wang, E. Abdelrahaman, V. Hadeed, M. A. Dyky, and A. Brufsky
Inhibin-B Levels in Healthy Young Adult Men and Prepubertal Boys: Is Obesity the Cause for the Contemporary Decline in Sperm Count Because of Fewer Sertoli Cells?
J Androl, July 1, 2006; 27(4): 560 - 564.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
U. Eiholzer, D. l'Allemand, V. Rousson, M. Schlumpf, T. Gasser, J. Girard, A. Gruters, and M. Simoni
Hypothalamic and Gonadal Components of Hypogonadism in Boys with Prader-Labhart- Willi Syndrome
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 892 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Bay, K. L. Matthiesson, R. I. McLachlan, and A.-M. Andersson
The Effects of Gonadotropin Suppression and Selective Replacement on Insulin-Like Factor 3 Secretion in Normal Adult Men
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1108 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Aksglaede, A. M. Wikstrom, E. R.-D. Meyts, L. Dunkel, N. E. Skakkebaek, and A. Juul
Natural history of seminiferous tubule degeneration in Klinefelter syndrome
Hum. Reprod. Update, January 1, 2006; 12(1): 39 - 48.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Fujita, A. Tsujimura, T. Takao, Y. Miyagawa, K. Matsumiya, M. Koga, M. Takeyama, H. Fujioka, K. Aozasa, and A. Okuyama
Expression of inhibin {alpha}, glial cell line-derived neurotrophic factor and stem cell factor in Sertoli cell-only syndrome: relation to successful sperm retrieval by microdissection testicular sperm extraction
Hum. Reprod., August 1, 2005; 20(8): 2289 - 2294.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
N. Sofikitis, E. Pappas, A. Kawatani, D. Baltogiannis, D. Loutradis, N. Kanakas, D. Giannakis, F. Dimitriadis, K. Tsoukanelis, I. Georgiou, et al.
Efforts to create an artificial testis: culture systems of male germ cells under biochemical conditions resembling the seminiferous tubular biochemical environment
Hum. Reprod. Update, May 1, 2005; 11(3): 229 - 259.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A F Radicioni, A Anzuini, E De Marco, I Nofroni, V D Castracane, and A Lenzi
Changes in serum inhibin B during normal male puberty
Eur. J. Endocrinol., March 1, 2005; 152(3): 403 - 409.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Luisi, P. Florio, F. M. Reis, and F. Petraglia
Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy
Hum. Reprod. Update, March 1, 2005; 11(2): 123 - 135.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. J. Buzzard, K. L. Loveland, M. K. O'Bryan, A. E. O'Connor, M. Bakker, T. Hayashi, N. G. Wreford, J. R. Morrison, and D. M. de Kretser
Changes in Circulating and Testicular Levels of Inhibin A and B and Activin A During Postnatal Development in the Rat
Endocrinology, July 1, 2004; 145(7): 3532 - 3541.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A.-M. Andersson, J. H. Petersen, N. Jorgensen, T. K. Jensen, and N. E. Skakkebaek
Serum Inhibin B and Follicle-Stimulating Hormone Levels as Tools in the Evaluation of Infertile Men: Significance of Adequate Reference Values from Proven Fertile Men
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2873 - 2879.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Almstrup, J. E. Nielsen, M. A. Hansen, M. Tanaka, N. E. Skakkebaek, and H. Leffers
Analysis of Cell-Type-Specific Gene Expression During Mouse Spermatogenesis
Biol Reprod, June 1, 2004; 70(6): 1751 - 1761.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Wikstrom, T. Raivio, F. Hadziselimovic, S. Wikstrom, T. Tuuri, and L. Dunkel
Klinefelter Syndrome in Adolescence: Onset of Puberty Is Associated with Accelerated Germ Cell Depletion
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2263 - 2270.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Lahlou, I. Fennoy, J.-C. Carel, and M. Roger
Inhibin B and Anti-Mullerian Hormone, But Not Testosterone Levels, Are Normal in Infants with Nonmosaic Klinefelter Syndrome
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1864 - 1868.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
P.-M. G. Bouloux, E. Nieschlag, H. G. Burger, N. E. Skakkebaek, F. C.W. Wu, D. J. Handelsman, G. H.W. Baker, R. Ochsenkuehn, A. Syska, R. I. Mclachlan, et al.
Induction of Spermatogenesis by Recombinant Follicle-Stimulating Hormone (Puregon) in Hypogonadotropic Azoospermic Men Who Failed to Respond to Human Chorionic Gonadotropin Alone
J Androl, July 1, 2003; 24(4): 604 - 611.
[Abstract] [Full Text] [PDF]


Home page